View Older Stories View More Recent Stories
-
Teragonia Expands AI Functionality for Healthcare
-
West Point Gold Intersects 66.2m of 6.57 g/t Au, including 20.7m of 18.25 g/t Au, Expanding the High-Grade NE Tyro Zone to Depth
-
Azarga Metals 2026 Marg Project Drill Program; Keno Hill District, Yukon
-
Golden Arrow Resources Announces US$25 Million Sale of 75% Owned Copper Assets at San Pietro Project; Secures Capital and Retains 9,000 ha of High-Potential Gold Targets
-
Gold Terra Announces 5.88 g/t Gold over 19.00 Metres Including 18.50 g/t Gold over 4.0 Metres in the Yellorex Area, Con Mine Option Property, Yellowknife, NWT
-
Founders Metals Hits 53.1 m of 1.21 g/t Au from Surface in New Zone West of Upper Antino; Froyo Zone Drilling Intersects 9.0 m of 12.21 g/t Au & 37.0 m of 3.27 g/t Au
-
Aclara Receives Positive Environmental Qualification Resolution For The Penco Module
-
Bitzero Expands Nordic Development Portfolio with Land Reservation Agreement for New Finland Site
-
Kirkland Lake Discoveries Extends Mirado System: 120 m South Step-Out Hits 79.63 g/t Au over 2.1 m; 100 m West Step-Out Intersects 0.98 g/t Au over 62.3 m
-
Tax1099 Expands Compliance Suite with Form 2290 E-Filing Ahead of HVUT Season
-
Reaves Utility Income Fund Increases Its Monthly Distribution 5% to $0.21 Per Share
-
Crescent Biopharma (CBIO) Reiterated at Buy by Stifel on CR-003/SKB105 Potential
-
Abu Dhabi's MGX Raises About $50 Billion To Accelerate AI Deals - Bloomberg
-
CopperTech Metals files for IPO on NYSE under ticker CUX
-
GCT Semiconductor shifts strategic focus toward AI edge connectivity
-
Booz Allen Hamilton (BAH) Reiterated at Buy by Stifel as Acquisition Agreement Announced
-
Nuvectis Pharma (NVCT) PT Raised to $39 at H.C. Wainwright
-
Fermi (FRMI) PT Lowered to $17 at Stifel on Forecast Updates
-
H.C. Wainwright Reiterates Buy Rating on Tscan Therapeutics Inc (TCRX)
-
H.C. Wainwright Reiterates Buy Rating on Verrica Pharmaceuticals (VRCA)
-
H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
-
H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
-
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
H.C. Wainwright Reiterates Buy Rating on Relmada Therapeutics Inc (RLMD)
-
H.C. Wainwright Reiterates Buy Rating on MapLight Therapeutics (MPLT)
-
H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
-
DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised
-
H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy
-
H.C. Wainwright Starts XCF Global (SAFX) at Buy
-
Domino's Pizza (DPZ) Reiterated at Buy by Benchmark as CEO Announces Retirement
-
Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
-
Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
-
Huron Consulting Group (HURN) Reiterated at Buy by Benchmark after Investor Call
-
Descartes adds audit logging tool to carrier selection platform
-
Jacobs to advise on New York's $1.7B public health lab
-
Patrick Industries (PATK) Reiterated at Buy by Benchmark amid Pressured NT Outlook
-
Cantor Fitzgerald Starts Factorial Energy (FAC) at Overweight
-
LCI Industries (LCII) PT Lowered to $125 at Benchmark on Reduced Estimates
-
Cantor Fitzgerald Starts Quince Therapeutics Inc. (QNCX) at Overweight
-
Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
-
Mizuho Reiterates Outperform Rating on EyePoint Inc. (EYPT)
-
RBC Capital Starts Opus Genetics (IRD) at Outperform
-
William Blair Starts The Campbell's Co. (CPB) at Market Perform
-
Accenture plc (ACN) PT Lowered to $226 at Mizuho
-
Primoris Services Corporation (PRIM) PT Lowered to $117 at Mizuho
-
Xcel Energy (XEL) PT Lowered to $91 at Mizuho
-
Mizuho Reiterates Outperform Rating on Darden Restaurants (DRI)
-
VIAVI launches Ultra Ethernet Transport validation tool for AI networks
-
Teleflex starts global pivotal trial for resorbable magnesium scaffold
